1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Tong Chen, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selinexor in Combination With MTX+Ritu to Treat R/R CNSL Selinexor, Rituximab, Methotrexate - Central Nervous System Lymphoma | Phase 1 / Phase 2 | Recruiting | Tong Chen, MD | 30 | 2023-08-03 | 2025-09-16 |
Methotrexate (1) · Rituximab (1) · selinexor (1)
China (1)
Tong Chen, Ph.D (1)